Cresco Labs (CRLBF) Amortization of Deferred Charges (2020 - 2026)

Cresco Labs has reported Amortization of Deferred Charges for 7 years, with the latest figure at $635000.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortization of Deferred Charges fell 47.56% year-over-year to $635000.0; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (down 28.71% YoY), and the FY2025 full-year result was $4.1 million, down 16.4% from the prior year.
• Amortization of Deferred Charges for Q1 2026 stood at $635000.0, down from $646000.0 in the prior quarter.
• The five-year high for Amortization of Deferred Charges was $1.7 million in Q2 2025, with the low at $517000.0 in Q3 2025.
• Historically, Amortization of Deferred Charges has averaged $1.1 million across 5 years, with a median of $1.1 million in 2023.
• Annual changes were most pronounced in 2022 — Amortization of Deferred Charges plunged 86.35% — and 2025, when it jumped 38.91%.
• Cresco Labs' Amortization of Deferred Charges stood at $1.0 million in 2022, then advanced by 14.97% to $1.2 million in 2023, then grew by 3.53% to $1.2 million in 2024, then tumbled by 46.21% to $646000.0 in 2025, then dropped by 1.7% to $635000.0 in 2026.
• The last three Amortization of Deferred Charges figures came in at $635000.0 (Q1 2026), $646000.0 (Q4 2025), and $517000.0 (Q3 2025), per Business Quant data.